The Impact of Artificial Intelligence on Value-Based Care in Orthopaedics

By Michael Awood

October 6, 2023

In healthcare, artificial intelligence has made considerable strides. It has the potential to enhance prediction, diagnosis, and decision-making. Researchers in orthopaedic surgery, where AI technologies have the potential to alter the discipline, have also seen this.

They can apply artificial intelligence in orthopaedics to find trends in data. Predicting patient risk potential or bad occurrences, for example, offers clinicians with crucial information. Despite the label “experimental,” there is mounting evidence that AI is successful and suitable for widespread use.

AI can help physicians and patients collaborate in the next steps. This points to a more cooperative intelligence. Physicians can give patient-specific risk-benefit ratios by feeding patient-reported outcomes into machine-learning algorithms. Doctors can use machine-learning algorithms to expect the results or advantages of arthroplasty surgery. However, we need further research to determine how these choice aids improve outcomes and provide value.

AI use in healthcare is fraught with ethical, legal, regulatory, and practise considerations. How should we get patients’ consent for AI-enabled robotic-assisted procedures? Surgeons must work with programmers to verify that the algorithm outputs match the demands of the patients.

It also poses questions regarding the current medical education programme, ultimately suggesting a redesign. Future professionals must learn to interact with and adapt to this technology for safe use in clinical settings.

However, there is a significant value proposition for AI in healthcare, particularly in terms of cost. AI technologies have the potential to reduce expenses by saving time and resources. These also impact patients’ experiences and outcomes. Getting clinician buy-in for the cultural shift, as well as assessing the initial cost, are essential concerns to balance against these potential savings.

AI has enormous potential in orthopaedics. To explore how artificial intelligence may aid orthopaedic patients, we need to test and assess it in clinics, prioritising its worth. According to the article, value is determined by weighing the advantages of new instruments against their entire expenses.

 

Cover image: stefamerpik on freepik

Reference url

Recent Posts

joint scientific consultations
        

Streamlining HTA – Joint Scientific Consultations in the EU

🌍 How can joint scientific consultations reshape the future of health technology in Europe?

The European Commission’s new regulation on joint scientific consultations under the Health Technology Assessment (HTA) Regulation offers a structured pathway for health technology developers to gain early insights on the clinical evidence required for assessments.

This initiative is set to enhance efficiency, foster collaboration, and ultimately improve patient access to innovative therapies.

Jump into the implications of this regulation for the healthcare landscape!

#SyenzaNews #HealthTechnology #HealthcareInnovation #MarketAccess

cost-effective CML treatment
      

Cost-Effective CML Treatment in South Africa

💡 *Are we getting the most value from our cancer treatments? *
A new study reveals that imatinib is the most cost-effective treatment option for chronic myeloid leukemia (CML) in South Africa, outperforming nilotinib and dasatinib both in costs and quality-adjusted life years (QALYs). This analysis emphasises critical implications for the South African healthcare system, emphasising the need for price negotiations to enhance treatment access.

Explore the findings and their impact on healthcare policy and resource allocation.

#SyenzaNews #HealthEconomics #CostEffectiveness #HealthcarePolicy

endometrial cancer mortality
      

Trends in Endometrial Cancer Mortality

💭 Are we doing enough to address ethnic disparities in endometrial cancer mortality?
A recent study highlights alarming trends in endometrial cancer mortality rates in South Africa, where rates have nearly doubled from 1999 to 2018, with significant variations among different ethnic groups. Understanding these disparities is crucial for developing targeted public health strategies to improve outcomes.

Look into the full article to explore the key insights and implications for healthcare policy and intervention strategies.

#SyenzaNews #globalhealth #healthcarepolicy

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.